Bandhan BSE Healthcare Index Fund - Direct Plan - Growth vs Tata India Pharma and Healthcare Fund Direct Plan Growth
NAV, returns and costs — not a recommendation.
 Bandhan BSE Healthcare Index Fund - Direct Plan - Growth |  Tata India Pharma and Healthcare Fund Direct Plan Growth | |
|---|---|---|
| NAV | ₹11.7383 | ₹39.7747 |
| NAV date | 2026-08-18 | 2026-08-18 |
| 1 year | +14.26% | +9.62% |
| 3 year (p.a.) | +8.58% | +20.31% |
| 5 year (p.a.) | +8.58% | +15.52% |
| Expense ratio | 0.19% | 0.67% |
| Fund size | ₹20.21 Cr | ₹1,455.16 Cr |
| Risk | Very high | — |
| Category | Index | Sectoral Pharma and Healthcare |
Past performance does not guarantee future returns. Mutual fund investments are subject to market risks.